Omega Fund V, L.P.

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$26.72M
Insider Sells Quantity
15
Insider Sells Sum
$61.36M

Insider Activity of Omega Fund V, L.P.

The largest purchase of all time was on 2020-10-14 and amounted to 900000 shares of Kronos Bio, Inc. for $17.1M.

The largest sale of all time was on 2021-11-03 and amounted to 2000000 shares of Nuvation Bio Inc. for $18.5M.

Biography of Omega Fund V, L.P.

No biography is available at this moment.

2021-12-15SaleNuvation Bio Inc.
NUVB
10 percent owner
500,000
0.2537%
$10.07$5.04M-64.26%
2021-12-07SaleNuvation Bio Inc.
NUVB
10 percent owner
1.4M
0.726%
$9.80$13.72M-61.57%
2021-11-23SaleNuvation Bio Inc.
NUVB
10 percent owner
36
<0.0001%
$9.75$351-57.14%
2021-11-22SaleNuvation Bio Inc.
NUVB
10 percent owner
295,000
0.1492%
$9.76$2.88M-58.82%
2021-11-03SaleNuvation Bio Inc.
NUVB
10 percent owner
2M
0.9862%
$9.25$18.5M-51.95%
2021-10-29SaleNuvation Bio Inc.
NUVB
10 percent owner
45,000
0.023%
$9.27$417,150-48.31%
2021-10-28SaleNuvation Bio Inc.
NUVB
10 percent owner
1.01M
0.5189%
$9.60$9.74M-50%
2020-10-14PurchaseKronos Bio, Inc.
KRON
10 percent owner
900,000
1.147%
$19.00$17.1M-14.59%
2019-09-20SaleGossamer Bio, Inc.
GOSS
10 percent owner
367,214
0.3016%
$10.98$4.03M-37.71%
2019-09-18SaleGossamer Bio, Inc.
GOSS
10 percent owner
91,200
0.076%
$10.94$997,637-36.53%
2019-09-17SaleGossamer Bio, Inc.
GOSS
10 percent owner
46,800
0.0387%
$10.81$505,791-36.23%
2019-09-16SaleGossamer Bio, Inc.
GOSS
10 percent owner
26,426
0.0219%
$10.76$284,331-35.41%
2019-09-11SaleGossamer Bio, Inc.
GOSS
10 percent owner
160,806
0.2646%
$21.31$3.43M-34.94%
2019-09-10SaleGossamer Bio, Inc.
GOSS
10 percent owner
64,746
0.1072%
$21.00$1.36M-33.48%
2019-09-06SaleGossamer Bio, Inc.
GOSS
10 percent owner
17,400
0.0151%
$10.75$187,103-31.7%
2019-09-05SaleGossamer Bio, Inc.
GOSS
10 percent owner
25,408
0.0217%
$10.80$274,434-33%
2019-05-09PurchaseTrevi Therapeutics, Inc.
TRVI
10 percent owner
962,000
6.6593%
$10.00$9.62M-42.9%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.